Terms: = Thyroid cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Clinical Outcome
9 results:
1. Comparison of thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone administration for adjuvant therapy in patients with intermediate- to high-risk differentiated thyroid cancer.
Iizuka Y; Katagiri T; Ogura K; Inoue M; Nakamura K; Mizowaki T
Ann Nucl Med; 2020 Oct; 34(10):736-741. PubMed ID: 32643022
[TBL] [Abstract] [Full Text] [Related]
2. Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of egfr and collagen IV and identification of their prognostic value in triple-negative breast cancer.
Zheng HM; Chen C; Wu XH; Chen J; Sun S; Sun JZ; Wang MW; Sun SR
Tumour Biol; 2016 Feb; 37(2):2509-18. PubMed ID: 26385773
[TBL] [Abstract] [Full Text] [Related]
3. Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Pelosi G; Haspinger ER; Bimbatti M; Leone G; Paolini B; Fabbri A; Tamborini E; Perrone F; Testi A; Garassino M; Maisonneuve P; de Braud F; Pilotti S; Pastorino U
Int J Surg Pathol; 2014 Apr; 22(2):136-48. PubMed ID: 24326823
[TBL] [Abstract] [Full Text] [Related]
4. Vandetanib: in medullary thyroid cancer.
Frampton JE
Drugs; 2012 Jul; 72(10):1423-36. PubMed ID: 22715896
[TBL] [Abstract] [Full Text] [Related]
5. Establishing an egfr mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.
Leary AF; Castro DG; Nicholson AG; Ashley S; Wotherspoon A; O'Brien ME; Popat S
Eur J Cancer; 2012 Jan; 48(1):61-7. PubMed ID: 22036089
[TBL] [Abstract] [Full Text] [Related]
6. clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.
Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC
Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026
[TBL] [Abstract] [Full Text] [Related]
7. Pulmonary adenocarcinoma with microcystic histology and intratumoral heterogeneity of egfr gene polymorphism.
Yeh YC; Chou TY
Histopathology; 2010 Jul; 57(1):112-20. PubMed ID: 20653783
[TBL] [Abstract] [Full Text] [Related]
8. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma.
Shah L; Walter KL; Borczuk AC; Kawut SM; Sonett JR; Gorenstein LA; Ginsburg ME; Steinglass KM; Powell CA
Cancer; 2004 Oct; 101(7):1632-8. PubMed ID: 15378500
[TBL] [Abstract] [Full Text] [Related]
9. Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease.
Kremser R; Obrist P; Spizzo G; Erler H; Kendler D; Kemmler G; Mikuz G; Ensinger C
Virchows Arch; 2003 Apr; 442(4):322-8. PubMed ID: 12715168
[TBL] [Abstract] [Full Text] [Related]
